JEFFREY F EISENBERG
CIK 1224096 · Chief Executive Officer · last filed 2023-12-13
JEFFREY F EISENBERG is a Chief Executive Officer who has filed 22 SEC Form 4 insider transactions across 4 companies since 2007. The most recent filing, for XBIOW, was dated Dec 13, 2023. Across all open-market trades the lifetime net is −$55.3K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $160.0K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$160.0K
4
22
-$55.3K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Xenetic Biosciences, Inc. (XBIOW) Delisted | Chief Executive Officer | — | $17.54 | — | $0 | 4 | 2023-12-13 |
| MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Delisted | Director | 64,558 | — | — | -$30.3K | 9 | 2018-02-23 |
| XBIO | CEO | 50,000 | $3.20 | $160.0K | $0 | 2 | 2017-10-30 |
| NOVEN PHARMACEUTICALS INC (NOVN) Delisted | Executive Vice President | 0 | $0.09 | $0 | -$25.0K | 6 | 2009-08-27 |
Recent Filings
22 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-13 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-03-28 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-03-22 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-06 | Xenetic Biosciences, Inc. (XBIOW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-02-23 | MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-24 | MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Delisted | Sell (S) | −35,442 | -$30.3K | EDGAR |
| 2018-01-12 | MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Delisted | Exer (M) | +100,000 | $0 | EDGAR |
| 2017-10-30 | XBIO | Grant (A) | +50,000 | $0 | EDGAR |
| 2017-10-04 | MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-18 | MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX) Delisted | Grant (A) | — | $0 | EDGAR |